SCHEMBL3900737

SCHEMBL3900737

c1ccc(C(=C(c2ccccc2)N(c2ccccc2)c2ccccc2)N(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
KMT2A Q03164 3/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
MAPT P10636 2/20 0.58
MEN1 O00255 2/20 0.58
HPGD P15428 2/20 0.58
GAA P10253 1/20 0.58
NPSR1 Q6W5P4 3/20 0.52
RAB9A P51151 4/20 0.43
NPC1 O15118 2/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
TDP1 Q9NUW8 2/20 0.41
ATM Q13315 1/20 0.41
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
DAO P14920 1/20 0.39
TSHR P16473 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707567 0.87 ALDH1A1 (0.52) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL3145058 0.84 ALDH1A1 (0.48) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL29682722 0.83 RELA (0.52) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL11673177 0.82 NPSR1 (0.52) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL13125584 0.77 CES2 (0.47) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL28613770 0.74 ALDH1A1 (1.00) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL8982783 0.74 ALDH1A1 (0.54) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL988299 0.74 ALDH1A1 (0.54) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL1003807 0.74 NPSR1 (0.61) ALDH1A1KMT2AL3MBTL1MAPTMEN1
SCHEMBL28118870 0.74 ALDH1A1 (0.54) ALDH1A1KMT2AL3MBTL1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090066238-A1 Electroluminescent materials grafted with charge transport moieties having graded ionization potential or electrophilic property and their application in light-emitting diodes NATIONAL TSING HUA UNIVERSITY (TW) 2009-03-12 US claimed
US-20150359884-A1 MULTI-PHOTON ISOMERISATION OF COMBRETASTATINS AND THEIR USE IN THERAPY BISBY ROGER H (GB) 2015-12-17 US disclosed
EP-2741776-A2 MULTI-PHOTON ISOMERISATION OF COMBRETASTATINS AND THEIR USE IN THERAPY The University of Salford (GB) 2014-06-18 EP disclosed
WO-2013021208-A2 MULTI-PHOTON ISOMERISATION OF COMBRETASTATINS AND THEIR USE IN THERAPY THE UNIVERSITY OF SALFORD (GB) 2013-02-14 WO disclosed
EP-1297021-B1 MULTIPHOTON PHOTOSENSITIZATION SYSTEM 3M INNOVATIVE PROPERTIES CO (US) 2009-03-18 EP disclosed
US-20090066238-A1 Electroluminescent materials grafted with charge transport moieties having graded ionization potential or electrophilic property and their application in light-emitting diodes NATIONAL TSING HUA UNIVERSITY (TW) 2009-03-12 US disclosed
US-7091255-B2 Multiphoton photosensitization system 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-08-15 US disclosed
US-20050054744-A1 Multiphoton photosensitization system 3M INNOVATIVE PROPERTIES COMPANY 2005-03-10 US disclosed
US-6852766-B1 Multiphoton photosensitization system 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-02-08 US disclosed
US-6624915-B1 System for forming switchable hologram comprising blank in path of two coherent energy beams which form areas of constructive interference and induce areas of photochemical change in blank due to absorption of two photons by chromogen SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2003-09-23 US disclosed
EP-1297021-A2 MULTIPHOTON PHOTOSENSITIZATION SYSTEM 3M Innovative Properties Company (US) 2003-04-02 EP disclosed
WO-2001096409-A2 MULTIPHOTON PHOTOSENSITIZATION SYSTEM 3M INNOVATIVE PROPERTIES COMPANY (US) 2001-12-20 WO disclosed
WO-2001071431-A1 HOLOGRAPHIC RECORDING AND MICRO/NANOFABRICATION VIA ULTRAFAST HOLOGRAPHIC TWO-PHOTON INDUCED PHOTOPOLYMERIZATION (H-TPIP) SCIENCE APPLICATIONS INTERNATIONAL CORP. (US) 2001-09-27 WO disclosed
EP-0535672-B1 Electrophotographic photoreceptor MITSUBISHI CHEM CORP (JP) 2001-01-03 EP disclosed
US-5389480-A Photosensitive layer containing stilbene and hydrazone type compounds; durability MITSUBISHI KASEI CORPORATION (JP) 1995-02-14 US disclosed
EP-0535672-A2 Electrophotographic photoreceptor Mitsubishi Chemical Corporation (JP) 1993-04-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150359884-A1 MULTI-PHOTON ISOMERISATION OF COMBRETASTATINS AND THEIR USE IN THERAPY SLC5A6, FLT4, FOLR2 ALDH1A1 2119/4885KMT2A 2593/4885L3MBTL1 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.